Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer-Reference-Cited by-同舟云学术

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

Published:1984-09-01 Issue:3 Volume:34 Page:323-328
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Holtkamp Wilhelm,Nagel Gerd Arno,Wander Hans-Erik,Rauschecker Helmut Franz,Heyden Dorit Von

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Thyroid-Stimulating Hormone and Prolactin Levels in Breast Cancer

2. Plasma prolactin levels and age in a female population: Relation to breast cancer

3. BMDP statistical software. University of California Press, Berkley (1981).

4. , , Medroxyprogesterone acetate high dose and bromocriptine results of a 4-year study in stage IV breast cancer. In: and (eds.), Role of medroxyprogesterone acetate in endocrine related tumors, Vol. II, Raven Press, New York (1983).

5. Prognostic significance of serum prolactin levels in advanced breast cancer

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition;BMC Cancer;2021-06-09

2. Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases;iScience;2020-10

3. Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer;Anticancer Research;2020-09

4. Giant prolactinoma, germline BRCA1 mutation, and depression: a case report;Journal of Medical Case Reports;2018-12

5. Spinale Mammakarzinommetastasen aus Sicht der Wirbelsäulenchirurgie;Der Orthopäde;2018-02-27